Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|December 8, 2004
Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivoA D Gritzapis, S A Perez, C N Baxevanis, et al.European Journal of Immunology|August 1, 1986
Evidence for distinct epitopes on human IgG with T cell proliferative and suppressor functionC N Baxevanis, C D Ioannides, G J Reclos, et al.Journal of Neuroimmunology|May 1, 1990
Prothymosin-alpha enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosisC N Baxevanis, C Sfagos, E Anastasopoulos, et al.Clinical Immunology and Immunopathology|April 1, 1994
Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgeryC N Baxevanis, K Papilas, G V Dedoussis, et al.Immunopharmacology|April 1, 1987
Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reactionC N Baxevanis, G J Reclos, S Perez, et al.Cancer Immunology, Immunotherapy : CII|August 31, 2002
Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatantsA D Gritzapis, D Dimitroulopoulos, E Paraskevas, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1995
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alphaC N Baxevanis, A D Gritzapis, G Spanakos, et al.Immunogenetics|January 1, 1980
Genetic control of T-cell proliferative responses to poly(glu40ala60) and poly(glu51lys34tyr15): subregion-specific inhibition of the responses with monoclonal Ia antibodiesC N Baxevanis, D Wernet, Z A Nagy, et al.British Journal of Cancer|October 1, 1994
Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectorsC N Baxevanis, G V Dedoussis, A D Gritzapis, et al.Advances in Experimental Medicine and Biology|January 1, 1988
Monocyte defect causes decreased autoMLR in multiple sclerosis patientsC N Baxevanis, G J Reclos, P Arsenis, et al.Pageof 7